SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies. | Signal Transduct Target Ther;6(1): 95, 2021 02 26. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies.

Yang, Yang; Du, Lanying.

Yang Y; Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, USA.
Du L; Howard Hughes Medical Institute, Yale University, New Haven, CT, USA.

Signal Transduct Target Ther ; 6(1): 95, 2021 02 26.

Article in English | MEDLINE | ID: covidwho-1104469

Subject(s)

COVID-19; Spike Glycoprotein, Coronavirus; Antibodies, Neutralizing; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus/genetics

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00523-5

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00523-5